Conditions: Hyperlipoproteinemia Metabolic Syndrome
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 12
Healthy volunteers: no

Brief summary:
The study is designed to evaluate the effect of Niacin/Laropiprant on postprandial lipoprotein metabolism, postprandial glucose metabolism, postprandial monocyte function, and postprandial biomarkers of endothelial dysfunction and inflammation.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Niacin/ Laropiprant
Intervention descriptions: intervention 1: 1000/ 20 mg first 4 weeks, 2000/40 mg next 8 weeks; daily

Protocol document: